Total Payments
$7,886
2024 Payments
$333.08
Companies
36
Transactions
522
Medicare Patients
5,825
Medicare Billing
$236,871
Payment Breakdown by Category
Food & Beverage$7,875 (99.8%)
Education$11.97 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,875 | 520 | 99.8% |
| Education | $11.97 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,342 | 89 | $0 (2024) |
| Novo Nordisk Inc | $615.00 | 42 | $0 (2024) |
| Astellas Pharma US Inc | $554.62 | 31 | $0 (2021) |
| PFIZER INC. | $548.35 | 49 | $0 (2021) |
| Lilly USA, LLC | $508.39 | 36 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $442.44 | 28 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $426.36 | 33 | $0 (2021) |
| Shire North American Group Inc | $351.67 | 21 | $0 (2018) |
| Amgen Inc. | $313.70 | 19 | $0 (2024) |
| Corcept Therapeutics | $277.71 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $333.08 | 17 | Lilly USA, LLC ($75.94) |
| 2023 | $82.37 | 4 | AbbVie Inc. ($50.39) |
| 2022 | $17.85 | 1 | Novo Nordisk Inc ($17.85) |
| 2021 | $1,128 | 70 | AstraZeneca Pharmaceuticals LP ($173.62) |
| 2020 | $1,203 | 77 | AstraZeneca Pharmaceuticals LP ($216.41) |
| 2019 | $1,668 | 105 | AstraZeneca Pharmaceuticals LP ($300.02) |
| 2018 | $1,595 | 113 | AstraZeneca Pharmaceuticals LP ($281.83) |
| 2017 | $1,859 | 135 | AstraZeneca Pharmaceuticals LP ($346.98) |
All Payment Transactions
522 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $42.66 | General |
| Category: Endocrinology | ||||||
| 08/21/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Inflammation | ||||||
| 06/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: PSYCHIATRY | ||||||
| 05/28/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Oncology | ||||||
| 05/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Diabetes | ||||||
| 04/10/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $15.73 | General |
| 03/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Diabetes | ||||||
| 02/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Diabetes | ||||||
| 02/22/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: VACCINE | ||||||
| 02/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Obesity | ||||||
| 02/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Diabetes | ||||||
| 01/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Diabetes | ||||||
| 01/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: NEUROSCIENCE | ||||||
| 01/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Diabetes | ||||||
| 01/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Cardiology | ||||||
| 12/12/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Diabetes | ||||||
| 11/16/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Diabetes | ||||||
| 11/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: NEUROSCIENCE | ||||||
| 02/11/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Diabetes | ||||||
| 10/07/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/17/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Diabetes | ||||||
| 08/25/2021 | ARBOR PHARMACEUTICALS, INC. | Edarbyclor (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,954 | 5,128 | $208,337 | $66,902 |
| 2022 | 34 | 2,750 | 7,019 | $317,488 | $115,605 |
| 2021 | 11 | 694 | 1,843 | $88,346 | $33,561 |
| 2020 | 9 | 427 | 1,102 | $63,660 | $20,802 |
Total Patients
5,825
Total Services
15,092
Medicare Billing
$236,871
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 342 | 402 | $78,323 | $30,894 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 106 | $13,600 | $6,295 | 46.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 42 | 43 | $11,260 | $5,133 | 45.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 277 | 517 | $21,318 | $4,257 | 20.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $15,198 | $4,015 | 26.4% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 23 | 27 | $4,320 | $3,429 | 79.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 90 | 91 | $9,100 | $3,123 | 34.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 53 | 108 | $4,104 | $1,734 | 42.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $5,016 | $1,404 | 28.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 46 | 47 | $3,760 | $975.09 | 25.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 76 | 83 | $1,205 | $697.20 | 57.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 60 | 64 | $1,784 | $653.63 | 36.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 71 | 78 | $1,950 | $587.14 | 30.1% |
| 74022 | X-ray series of abdomen with single x-ray of chest | Office | 2023 | 14 | 14 | $1,750 | $503.02 | 28.7% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 12 | 14 | $1,050 | $436.02 | 41.5% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 22 | 23 | $875.00 | $372.60 | 42.6% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 15 | 15 | $1,650 | $372.32 | 22.6% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 17 | 18 | $1,584 | $357.53 | 22.6% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 14 | 16 | $1,376 | $290.39 | 21.1% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 196 | 856 | $15,300 | $283.78 | 1.9% |
| 73610 | X-ray of ankle, minimum of 3 views | Office | 2023 | 11 | 13 | $1,144 | $277.85 | 24.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 79 | 84 | $924.00 | $258.60 | 28.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 18 | $1,033 | $178.99 | 17.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 213 | 2,195 | $7,385 | $167.25 | 2.3% |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | Office | 2023 | 15 | 18 | $180.00 | $85.48 | 47.5% |
About Dr. William Taunton, M.D
Dr. William Taunton, M.D is a Family Medicine healthcare provider based in Tuscaloosa, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1548482995.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Taunton, M.D has received a total of $7,886 in payments from pharmaceutical and medical device companies, with $333.08 received in 2024. These payments were reported across 522 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($7,875).
As a Medicare-enrolled provider, Taunton has provided services to 5,825 Medicare beneficiaries, totaling 15,092 services with total Medicare billing of $236,871. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Tuscaloosa, AL
- Active Since 05/03/2007
- Last Updated 09/23/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1548482995
Products in Payments
- FARXIGA (Drug) $1,125
- MYRBETRIQ (Drug) $478.52
- XIFAXAN (Drug) $309.05
- MYDAYIS (Drug) $280.37
- XARELTO (Drug) $279.94
- CHANTIX (Drug) $278.11
- Korlym (Drug) $277.71
- TRADJENTA (Drug) $271.66
- TRULICITY (Drug) $248.77
- Ozempic (Drug) $243.59
- Vascepa (Drug) $208.27
- Aimovig (Biological) $171.05
- REXULTI (Drug) $166.90
- TOUJEO (Drug) $159.98
- ENTRESTO (Drug) $148.26
- INVOKANA (Drug) $146.42
- Quillivant XR (Drug) $144.24
- SOLIQUA (Drug) $122.47
- VRAYLAR (Drug) $111.07
- MOUNJARO (Drug) $107.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Tuscaloosa
Kelly Hunter, M.d, M.D
Family Medicine — Payments: $54,314
Family Medicine $54,314
Dr. Craig Buettner, Md, MD
Family Medicine — Payments: $20,694
Family Medicine $20,694
Dr. Jeffery Laubenthal, Md, MD
Family Medicine — Payments: $20,425
Family Medicine $20,425
Katherine Grelle, Md, MD
Family Medicine — Payments: $11,665
Family Medicine $11,665
Remona Peterson, Md, MD
Family Medicine — Payments: $8,135
Family Medicine $8,135
Dr. Jennifer Burdette, M.d, M.D
Family Medicine — Payments: $7,603
Family Medicine $7,603